"10.1371_journal.pone.0121556","plos one","2015-03-23T00:00:00Z","Anchel González-Barriga; Julia Kranzen; Huib J E Croes; Suzanne Bijl; Walther J A A van den Broek; Ingeborg D G van Kessel; Baziel G M van Engelen; Judith C T van Deutekom; Bé Wieringa; Susan A M Mulders; Derick G Wansink","Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands; Department of Neurology, Donders Centre for Neuroscience, Radboud university medical center, Nijmegen, The Netherlands; Prosensa Therapeutics B.V., Leiden, The Netherlands","Conceived and designed the experiments: AGB JCTvD SAMM DGW. Performed the experiments: AGB JK HJEC SB WJAAvdB IDGvK. Analyzed the data: AGB JK HJEC SB WJAAvdB IDGvK JCTvD BW SAMM DGW. Contributed reagents/materials/analysis tools: BGMvE. Wrote the paper: AGB BW DGW.","AGB, SB, JCTvD and SAMM are employees (which includes contribution to patent [applications] and participation in stockoption plans) of Prosensa Therapeutics BV, a company that develops RNA therapeutics for Duchenne muscular dystrophy and other neuromuscular disorders. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Anchel González-Barriga","AGB",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
